基本信息
浏览量:2
职业迁徙
个人简介
Dr. Gariépy has had a long standing interest in developing new technologies in the field of biotherapeutics, being cited as an inventor or co-inventor on 8 granted patents and on more than 20 patent applications.More recently, his group has developed and is studying the mechanism of action of several novel protein-based biologics that behave as powerful immune checkpoint agonists. Finally, his group has been developing a preventive vaccine against metastatic cancer.
研究兴趣
论文共 169 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Minzhi Sheng, Gobi Thillainadesan,Amanda Sparkes,Boyang Su, Esther Matus, Jessica Wright,Stanley Liu,Jean Gariepy,Hon S. Leong
Cancer Researchno. 6_Supplement (2024): 61-61
Elizabeth Scheid, Pierre Major,Alain Bergeron,Olivera J. Finn,Russell D. Salter, Robin Eady,Bader Yassine-Diab,David Favre,Yoav Peretz, Claire Landry,Sebastien Hotte,Som D. Mukherjee,
crossref(2023)
Elizabeth Scheid, Pierre Major,Alain Bergeron,Olivera J. Finn,Russell D. Salter, Robin Eady,Bader Yassine-Diab,David Favre,Yoav Peretz, Claire Landry,Sebastien Hotte,Som D. Mukherjee,
crossref(2023)
crossref(2023)
Journal of the National Cancer Instituteno. 10 (2023): 1145-1156
Elizabeth Scheid,Pierre Major,Alain Bergeron,Olivera J. Finn,Russell D. Salter, Robin Eady,Bader Yassine-Diab,David Favre,Yoav Peretz, Claire Landry,Sebastien Hotte,Som D. Mukherjee,
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn